- No Items For Such Parameters.
- Merus Announces Fourth Quarter and Full Year 2016 Financial Results and Corporate Developments
- Basilea shareholders approve all resolutions proposed by the Board of Directors at the Ordinary General Meeting of Shareholders
- Publication of the definitive notice of the end result of Actelion tender offer
- Alcon announces EU launch of CyPass® Micro-Stent, a micro invasive glaucoma surgical device, to lower intraocular pressure (IOP) in patients with primary open-angle glaucoma
- Novartis delivered sales growth across all divisions (cc1) as growth drivers, including Cosentyx and Entresto, more than offset generic erosion; innovation momentum continued